Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep

Parasite Immunology

Volumn 19, Issue 5, 1997, Pages 221-227

  Rothel, J S ^a,c   Boyle, D B ^b   Both, G W ^b   Pye, A D ^b   Waterkeyn, J G ^a   Wood, P R ^b   Lightowlers, M W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSIRO   (Australia)

^c CSL LIMITED   (Australia)

Author keywords

adenovirus; nucleic acid; recombinant; Taenia ovis; vaccine

Indexed keywords

DNA VACCINE; IMMUNOLOGICAL ADJUVANT; NUCLEIC ACID; PARASITE ANTIGEN; RECOMBINANT PROTEIN;

ADENOVIRUS; ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CESTODE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; SUBCONJUNCTIVAL DRUG ADMINISTRATION; TAENIASIS; VACCINATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; CESTODA; OVIS; OVIS ARIES; TAENIA OVIS;

EID: 0031006689     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1997.d01-200.x     Document Type: Article

References (20)

1. Boyle D.B. (1994) Viral vaccines for animal disease control. In: Vaccines in Agriculture: Immunological Applications to Animal Health and Production, P.R. Wood, P. Willadsen, J.E. Vercoe, R.M. Hoskinson, & D. and Demeyer, eds. pp. 187-192. CSIRO, East Melbourne, Australia
2. Boyle D.B., Pye A.D., Kocherhans R., Adair B.M., Vrati S. & Both G.W. (1994) Characterisation of Australian ovine adenovirus isolates. Veterinary Microbiology 41, 281-291
3. Cooney E.L., Collier A.C., Greenhurg P.D., Coombs R.W., Zarling J., Arditti D.E., Hoffman MC., Hu S.-L. & Corey L. (1991) Safety of and immunological response to a recombinant vaccinia virus expressing HIV envelope glycoprotein. Lancet 337, 567-572
4. Cooney E.L., McElrath M.J., Corey L. et al. (1993) Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proceedings of the National Academy of Sciences, USA 90, 1882-1886
5. Hodgson A.L.M. (1994) Bacterial vaccine vectors. In: Vaccines in Agriculture: Immunological Applications to Animal Health and Production, P.R. Wood, P. Willadsen, J.E. Vercoe, R.M. Hoskinson, & D. and Demeyer eds, pp. 177-186 CSIRO, East Melbourne, Australia
6. Hu S.-L., Abrams K., Barber G.N. et al. (1992) Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255, 456-459
7. Iritani Y., Aoyama S. et al. (1991) Antibody responses to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV. Avian Diseases 35, 659-661
8. Johnson K.S., Harrison G.B.L., Lightowlers M.W. et al. (1989) Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature 338, 585-587
9. Konishi E., Pincus S., Paoletti E., Shope R.E. & Mason P.W. (1994) Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 12, 633-638
10. Leong K.H., Ramsay A.J., Ramshaw I.A., Morin M.J., Robinson H.L. & Boyle D.B. (1995) Generation of enhanced immune responds by consecutive immunization with DNA and recombinant fowl pox vectors. In: Vaccines 95, pp. 327-331, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
11. Lightowlers M.W., Waterkeyn J.G., Rothel J.S., Gauci C.G. & Harrison G.B.L. (1996) Host-protective fragments and anitbody binding epitopes of Taenia ovis 45W recombinant antigen. Parasite Immunology 18, 507-513
12. Mosier D.E., Gulizia R.J., MacIsaac P.D., Corey L. & Greenburg P.D. (1993) Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proceedings of the National Academy of Sciences. USA 90, 2443-2447
13. Proudfoot N.J. & Brownlee G.G. (1986) 3′ non-coding region sequences in eukaryotic mRNAs. Nature 263, 211-214
14. Pye D. (1989) Cell lines for growth of sheep viruses. Australian Veterinary Journal 66, 231
15. Rothel J.S., Lightowlers M.W., Seow H.-F., Wood P.R., Heath D.D. & Harrison G.B.L. (1996) Immune responses associated with protection in sheep vaccinated with a recombinant antigen from Taenia ovis. Parasit Immunology 18, 201-208
16. Rothel J.S., Waterkeyn J., Strugnell R.A., Wood P.R., Seow H.-F., Vadolas J. & Lightowlers M.W. (1997) Nucleic acid vaccination of sheep: use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunology and Cell Biology 75, 41-46
17. Vogel F.R. & Sarver N. (1995) Nucleic acid vaccines. Clinical Microbiology Reviews 8, 406-410
18. Vrati S., Boyle D.B., Kocherhans R. & Both G.W. (1995) Sequence of ovine adenovirus 100k hexon assembly, 33k, pVIII and fiber genes: Early region E3 is not in the expected location. Virology 209, 400-408
19. Vrati S., Brookes D.E., Boyle D.B. & Both G.W. (1996a) Nucleotide sequence of ovine adenovirus tripartite leader sequence and homologues of the IVa2, DNA polymerase and terminal proteins. Gene 177, 35-41
20. Vrati S., MacAvoy E.S., Xu Z.Z., Smole C., Boyle D.B. & Both G.W. (1996b) Construction and transfection of ovine adenovirus genomic clones to rescue modified viruses. Virology 220, 200-203